AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-85 |
Results: 76-85/85

Authors: Ankersen, M Hansen, BS Hansen, TK Lau, J Peschke, B Madsen, K Johansen, NL
Citation: M. Ankersen et al., Demonstration of the strength of focused combinatorial libraries in SAR optimisation of growth hormone secretagogues, EUR J MED C, 34(10), 1999, pp. 783-790

Authors: Lau, WY Leung, TWT Ho, SKW Chan, M Machin, D Lau, J Chan, ATC Yeo, W Mok, TSK Yu, SCH Leung, NWY Johnson, PJ
Citation: Wy. Lau et al., Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial, LANCET, 353(9155), 1999, pp. 797-801

Authors: Sams, CK Lau, J
Citation: Ck. Sams et J. Lau, Solid-phase synthesis of 1,2,4-oxadiazoles, TETRAHEDR L, 40(52), 1999, pp. 9359-9362

Authors: Andersen, KE Sorensen, JL Huusfeldt, PO Knutsen, LJS Lau, J Lundt, BF Petersen, H Suzdak, PD Swedberg, MDB
Citation: Ke. Andersen et al., Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates, J MED CHEM, 42(21), 1999, pp. 4281-4291

Authors: Knutsen, LJS Andersen, KE Lau, J Lundt, BF Henry, RF Morton, HE Naerum, L Petersen, H Stephensen, H Suzdak, PD Swedberg, MDB Thomsen, C Sorensen, PO
Citation: Ljs. Knutsen et al., Synthesis of novel GABA uptake inhibitors. 3. Diaryloxime and diarylvinyl ether derivatives of nipecotic acid and guvacine as anticonvulsant agents, J MED CHEM, 42(18), 1999, pp. 3447-3462

Authors: Knutsen, LJS Lau, J Petersen, H Thomsen, C Weis, JU Shalmi, M Judge, ME Hansen, AJ Sheardown, MJ
Citation: Ljs. Knutsen et al., N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects, J MED CHEM, 42(18), 1999, pp. 3463-3477

Authors: Jorgensen, TK Andersen, KE Lau, J Madsen, P Huusfeldt, PO
Citation: Tk. Jorgensen et al., Synthesis of substituted 10,11-dihydro-5H-dibenz[b,f]azepines; Key synthons in syntheses of pharmaceutically active compounds, J HETERO CH, 36(1), 1999, pp. 57-64

Authors: Soulis, T Sastra, S Thallas, V Mortensen, SB Wilken, M Clausen, JT Bjerrum, OJ Petersen, H Lau, J Jerums, G Boel, E Cooper, ME
Citation: T. Soulis et al., A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes, DIABETOLOG, 42(4), 1999, pp. 472-479

Authors: Lau, J Fu, H Cane, DE Khosla, C
Citation: J. Lau et al., Dissecting the role of acyltransferase domains of modular polyketide synthases in the choice and stereochemical fate of extender units, BIOCHEM, 38(5), 1999, pp. 1643-1651

Authors: Ioannidis, JPA Lau, J
Citation: Jpa. Ioannidis et J. Lau, Heterogeneity of the baseline risk within patient populations of clinical trials - A proposed evaluation algorithm, AM J EPIDEM, 148(11), 1998, pp. 1117-1126
Risultati: 1-25 | 26-50 | 51-75 | 76-85 |